Literature DB >> 19545546

Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Erick T Tatro1, Ian P Everall, Marcus Kaul, Cristian L Achim.   

Abstract

Mood disorders associated with dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis are common psychiatric conditions. The glucocorticoid receptor (GR) is a steroid-activated nuclear receptor that, upon binding to cortisol, translocates to the nucleus where it targets genes related to neuronal metabolism and plasticity. In patients suffering from major depressive disorder (MDD), hypercortisolemia is a common finding. In the current study we investigated the molecular events associated with the FK506 binding proteins (FKBP) -52 and -51 response to cortisol exposure in neuronal cell cultures and their effect on GR translocation. We noted that FK506 altered nuclear localization of the GR and inhibited expression of GR-responsive genes. Furthermore, siRNA knockdown of FKBP4 gene, coding for the immunophilin FKBP52, inhibited cortisol-activated GR nuclear translocation, while knockdown of FKBP5, coding for immunophilin FKBP51, was associated with increased baseline GR nuclear localization. We propose that immunophilins are modulators of the cortisol-HPA axis response to stress and related chronic brain disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545546      PMCID: PMC2724600          DOI: 10.1016/j.brainres.2009.06.036

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

Review 1.  Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.

Authors:  C M Pariante; A H Miller
Journal:  Biol Psychiatry       Date:  2001-03-01       Impact factor: 13.382

Review 2.  Role of molecular chaperones in subnuclear trafficking of glucocorticoid receptors.

Authors:  D B Defranco
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

3.  Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.

Authors:  Elisabeth B Binder; Rebekah G Bradley; Wei Liu; Michael P Epstein; Todd C Deveau; Kristina B Mercer; Yilang Tang; Charles F Gillespie; Christine M Heim; Charles B Nemeroff; Ann C Schwartz; Joseph F Cubells; Kerry J Ressler
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

4.  Pathophysiology of hypercortisolism in depression.

Authors:  B J Carroll; F Cassidy; D Naftolowitz; N E Tatham; W H Wilson; A Iranmanesh; P Y Liu; J D Veldhuis
Journal:  Acta Psychiatr Scand Suppl       Date:  2007

5.  The microtubule-associated protein doublecortin-like regulates the transport of the glucocorticoid receptor in neuronal progenitor cells.

Authors:  Carlos P Fitzsimons; Suaad Ahmed; Christiaan F W Wittevrongel; Theo G Schouten; Thomas F Dijkmans; Wim J J M Scheenen; Marcel J M Schaaf; E Ronald de Kloet; Erno Vreugdenhil
Journal:  Mol Endocrinol       Date:  2007-11-01

Review 6.  Mice that under- or overexpress glucocorticoid receptors as models for depression or posttraumatic stress disorder.

Authors:  Sabine Chourbaji; Miriam A Vogt; Peter Gass
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

7.  Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model.

Authors:  K Kohda; K Harada; K Kato; A Hoshino; J Motohashi; T Yamaji; S Morinobu; N Matsuoka; N Kato
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

Review 8.  The stress system in depression and neurodegeneration: focus on the human hypothalamus.

Authors:  A-M Bao; G Meynen; D F Swaab
Journal:  Brain Res Rev       Date:  2007-04-27

9.  FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness.

Authors:  Xinyu Zhang; Abbot F Clark; Thomas Yorio
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

10.  Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits.

Authors:  Micha Gawlik; Kerstin Moller-Ehrlich; Meinhard Mende; Michael Jovnerovski; Sven Jung; Burkhard Jabs; Michael Knapp; Gerald Stoeber
Journal:  BMC Psychiatry       Date:  2006-11-02       Impact factor: 3.630

View more
  52 in total

1.  Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus-infected individuals.

Authors:  Erick T Tatro; Timothy B Nguyen; Chad A Bousman; Eliezer Masliah; Igor Grant; J Hampton Atkinson; Ian P Everall
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

2.  HIV-1 proteins accelerate HPA axis habituation in female rats.

Authors:  Leonidas Panagiotakopoulos; Sean Kelly; Gretchen N Neigh
Journal:  Physiol Behav       Date:  2015-02-07

Review 3.  Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor.

Authors:  Chase H Bourke; Constance S Harrell; Gretchen N Neigh
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

Review 4.  Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad.

Authors:  Mandakh Bekhbat; Sydney A Rowson; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2017-05-11       Impact factor: 8.606

5.  The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder.

Authors:  Haiyin Li; Ping Su; Terence Ky Lai; Anlong Jiang; Jing Liu; Dongxu Zhai; Charlie Tg Campbell; Frankie Hf Lee; WeiDong Yong; Suvercha Pasricha; Shupeng Li; Albert Hc Wong; Kerry J Ressler; Fang Liu
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 6.  Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.

Authors:  Laura J Blair; Jonathan J Sabbagh; Chad A Dickey
Journal:  Expert Opin Ther Targets       Date:  2014-07-29       Impact factor: 6.902

7.  FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Authors:  Katarzyna A Ellsworth; Irene Moon; Bruce W Eckloff; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Joanna M Biernacka; Ryan Abo; Abra Brisbin; Yuan Ji; Scott Hebbring; Eric D Wieben; David A Mrazek; Richard M Weinshilboum; Liewei Wang
Journal:  Pharmacogenet Genomics       Date:  2013-03       Impact factor: 2.089

Review 8.  Childhood adversity and epigenetic regulation of glucocorticoid signaling genes: Associations in children and adults.

Authors:  Audrey R Tyrka; Kathryn K Ridout; Stephanie H Parade
Journal:  Dev Psychopathol       Date:  2016-10-03

9.  The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum.

Authors:  Marcin Piechota; Michal Korostynski; Wojciech Solecki; Agnieszka Gieryk; Michal Slezak; Wiktor Bilecki; Barbara Ziolkowska; Elzbieta Kostrzewa; Iwona Cymerman; Lukasz Swiech; Jacek Jaworski; Ryszard Przewlocki
Journal:  Genome Biol       Date:  2010-05-04       Impact factor: 13.583

10.  Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila.

Authors:  Reiko Sanokawa-Akakura; Weihuan Cao; Kirsten Allan; Khyati Patel; Anupama Ganesh; Gary Heiman; Richard Burke; Francis W Kemp; John D Bogden; James Camakaris; Raymond B Birge; Mary Konsolaki
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.